{"id":"W1920830047","doi":"10.1111/dom.12589","title":"Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Medtronic; Sanofi-Aventis Korea Company; Janssen Research and Development; Novartis; Eli Lilly and Company","keywords":"Canagliflozin; Medicine; Placebo; Incretin; Type 2 diabetes; Sitagliptin; Glucagon-like peptide 1 receptor; Internal medicine; Pharmacology; Endocrinology; Adverse effect; Dipeptidyl peptidase-4; Urology; Agonist; Diabetes mellitus; Gastroenterology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003288352,0.0004030483,0.001797618,0.0004380495,0.0002406844,0.0009253316,0.0003233902,0.001000846,0.0008757171],"category_scores_gemma":[0.005635519,0.000301463,0.001507824,0.0005164226,0.0004746224,0.0005314927,0.0003241873,0.001076835,0.0001445479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004607987,"about_ca_system_score_gemma":0.0003973561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004537862,"about_ca_topic_score_gemma":0.0008235787,"domain_scores_codex":[0.9981939,0.0009170761,0.0001688541,0.0002526728,0.000377532,0.0000899376],"domain_scores_gemma":[0.9975127,0.001326133,0.0006703323,0.0001275349,0.0001269559,0.000236319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6521841,0.006533839,0.1291226,0.001575212,0.009404875,0.0002716728,0.0002134957,0.002035136,0.01057523,0.0001040683,0.0008457473,0.1871341],"study_design_scores_gemma":[0.1367781,0.2707729,0.5632732,0.0003698644,0.0131985,0.000987604,0.0002251734,0.004579443,0.006452661,0.0003793197,0.002883254,0.0001000334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881294,0.009933523,0.0001896596,0.0002151056,0.0001102713,0.00007980599,0.0001381348,0.00001593235,0.00118824],"genre_scores_gemma":[0.9977621,0.001315023,0.0002402638,0.0002256482,0.0001477207,0.00004109257,0.0001411683,0.000002289415,0.0001247034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003288352,"threshold_uncertainty_score":0.01739073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009532739788251,"score_gpt":0.2029113262920717,"score_spread":0.1933785865038207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}